Paper3486045
Endotoxin-mediated necrosis and regression of established tumours in the mouse. A correlative study of quantitative changes in blood flow and ultrastructural morphology.
MacPherson GG and 1 other. Cancer Immunol Immunother, 1986. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. Endotoxin-mediated necrosis and regression of established tumours in the mouse. A correlative study of quantitative changes in blood flow and ultrastructural morphology. Papers, record 3486045. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3486045
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Endotoxins | Major topic |
| Neoplasms, Experimental | Major topic |
| Animals | |
| Cardiac Output | |
| Glycoproteins | |
| Macrophage Activation | |
| Mice | |
| Mice, Inbred C57BL | |
| Necrosis | |
| Neutrophils | |
| Phagocytes | |
| T-Lymphocytes | |
| Tumor Necrosis Factor-alpha |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6196106 | Antitumour activity of endotoxin, concanavalin A and poly I: C and their ability to elicit tumour necrosis factor, cytostatic factors, and interferon in vivo. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6196106 | PubMed |
| 2 | 333124 | Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse. | J Natl Cancer Inst | 1977 | https://conductscience.org/library/papers/333124 | PubMed |
| 3 | 13741297 | Embedding in epoxy resins for ultrathin sectioning in electron microscopy. | Stain Technol | 1960 | https://conductscience.org/library/papers/13741297 | PubMed |
| 4 | 1000787 | Tumor necrosis factor. | Clin Bull | 1976 | https://conductscience.org/library/papers/1000787 | PubMed |
| 5 | 6391656 | The therapeutic significance of concomitant antitumor immunity. II. Passive transfer of concomitant immunity with Ly-1+2- T cells primes established tumors in T cell-deficient recipients for endotoxin-induced regression. | Cancer Immunol Immunother | 1984 | https://conductscience.org/library/papers/6391656 | PubMed |
| 7 | 4713170 | Similarities of the anti-tumour actions of endotoxin, lipid A and double-stranded RNA. | Br J Cancer | 1973 | https://conductscience.org/library/papers/4713170 | PubMed |
| 8 | 13850016 | Mechanisms of the hemodynamic effects of endotoxin. | Physiol Rev | 1960 | https://conductscience.org/library/papers/13850016 | PubMed |
| 9 | 309922 | The immunological basis of endotoxin-induced tumor regression. Requirement for a pre-existing state of concomitant anti-tumor immunity. | J Exp Med | 1978 | https://conductscience.org/library/papers/309922 | PubMed |
| 10 | 6563942 | Role of histamine in the antitumour activity of endotoxin. | Cancer Immunol Immunother | 1984 | https://conductscience.org/library/papers/6563942 | PubMed |
| 11 | 6319531 | Local opsonization by secreted macrophage complement components. Role of receptors for complement in uptake of zymosan. | J Exp Med | 1984 | https://conductscience.org/library/papers/6319531 | PubMed |
| 12 | 6177893 | Murine tumor necrosis-inducing factor: purification and effects on myelomonocytic leukemia cells. | J Natl Cancer Inst | 1982 | https://conductscience.org/library/papers/6177893 | PubMed |
| 13 | 6444236 | T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor. | J Exp Med | 1980 | https://conductscience.org/library/papers/6444236 | PubMed |
| 14 | 5547059 | The mediator of cellular immunity. 3. Lymphocyte traffic from the blood into the inflamed peritoneal cavity. | J Exp Med | 1971 | https://conductscience.org/library/papers/5547059 | PubMed |
| 16 | 458374 | Regional blood flow and its relationship to lymphocyte and lymphoblast traffic during a primary immune reaction. | J Exp Med | 1979 | https://conductscience.org/library/papers/458374 | PubMed |
| 18 | 25290972 | Is tumor necrosis factor a physiological mediator? | Immunol Today | 1984 | https://conductscience.org/library/papers/25290972 | PubMed |
| 19 | 6334549 | The therapeutic significance of concomitant antitumor immunity. I. LY-1-2+ T cells from mice with a progressive tumor can cause regression of an established tumor in gamma-irradiated recipients. | Cancer Immunol Immunother | 1984 | https://conductscience.org/library/papers/6334549 | PubMed |
| 20 | 1103152 | An endotoxin-induced serum factor that causes necrosis of tumors. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/1103152 | PubMed |
| 21 | 1167565 | Polymorphonuclear leukocytes in antibody-dependent cellular cytotoxicity. | J Immunol | 1975 | https://conductscience.org/library/papers/1167565 | PubMed |
| 22 | 6370831 | The role of the macrophage in cardiac allograft rejection in the rat. | Immunol Rev | 1984 | https://conductscience.org/library/papers/6370831 | PubMed |
| 23 | 6368247 | Role of mononuclear phagocyte function in endotoxin-induced tumor necrosis. | Eur J Cancer Clin Oncol | 1984 | https://conductscience.org/library/papers/6368247 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38673758 | Spin Trapping of Nitric Oxide by Hemoglobin and Ferrous Diethyldithiocarbamate in Model Tumors Differing in Vascularization. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38673758 | PubMed |
| 36971591 | Translatable Drug-Loaded Iron Oxide Nanophore Sensitizes Murine Melanoma Tumors to Monoclonal Antibody Immunotherapy. | ACS Nano | 2023 | https://conductscience.org/library/papers/36971591 | PubMed |
| 8980389 | Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8980389 | PubMed |
| 8579110 | Hypoxic tumor cell death and modulation of endothelial adhesion molecules in the regression of granulocyte colony-stimulating factor-transduced tumors. | Am J Pathol | 1996 | https://conductscience.org/library/papers/8579110 | PubMed |
| 7686211 | Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma. | J Exp Med | 1993 | https://conductscience.org/library/papers/7686211 | PubMed |
| 3115109 | Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors. | Am J Pathol | 1987 | https://conductscience.org/library/papers/3115109 | PubMed |
| 2292139 | Vascular attack as a therapeutic strategy for cancer. | Cancer Metastasis Rev | 1990 | https://conductscience.org/library/papers/2292139 | PubMed |
| 1744160 | Influence of recombinant tumour necrosis factor alpha on blood flow and antibody localisation in human tumour xenografts in nude mice. | J Cancer Res Clin Oncol | 1991 | https://conductscience.org/library/papers/1744160 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3486045
GET https://conductscience.org/api/papers/v1/3486045/references?page=2